SCHEMBL20568765

SCHEMBL20568765

O=C(Nc1ccc(OC(=O)Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cc1)Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.72
MEN1 O00255 2/20 0.72
MAPT P10636 2/20 0.72
HTT P42858 2/20 0.72
LMNA P02545 1/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
NPSR1 Q6W5P4 1/20 0.72
RAB9A P51151 1/20 0.71
KDR P35968 10/20 0.69
MAPK14 Q16539 10/20 0.69
TNNI3K Q59H18 10/20 0.69
BRAF P15056 8/20 0.69
CDK8 P49336 3/20 0.65
CDK7 P50613 1/20 0.65
CDK6 Q00534 1/20 0.65
ALDH1A1 P00352 1/20 0.61
BAZ1A Q9NRL2 1/20 0.58
MTOR P42345 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20568683 0.90 MEN1 (0.74) KMT2AMEN1MAPTHTTLMNA
SCHEMBL6370472 0.86 MAPT (0.72) KMT2AMEN1MAPTHTTLMNA
SCHEMBL5597699 0.85 KMT2A (0.90) KMT2AMEN1MAPTHTTLMNA
SCHEMBL30101230 0.85 KMT2A (0.90) KMT2AMEN1MAPTHTTLMNA
SCHEMBL30069239 0.84 MAPT (1.00) KMT2AMEN1MAPTHTTLMNA
SCHEMBL17609423 0.84 MAPT (1.00) KMT2AMEN1MAPTHTTLMNA
SCHEMBL4548162 0.83 KMT2A (0.87) KMT2AMEN1MAPTHTTLMNA
SCHEMBL4548157 0.83 MAPT (0.79) KMT2AMEN1MAPTHTTLMNA
SCHEMBL22092703 0.82 MAPT (0.79) KMT2AMEN1MAPTHTTLMNA
SCHEMBL29494989 0.82 MAPT (0.79) KMT2AMEN1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601752-A Novel inhibitors of MAP4K1 伊克诺斯科学公司 2021-04-02 CN disclosed
EP-3630778-A1 NOVEL INHIBITORS OF MAP4K1 Ichnos Sciences SA (CH) 2020-04-08 EP disclosed
WO-2018215668-A1 NOVEL INHIBITORS OF MAP4K1 GLENMARK PHARMACEUTICALS S.A. (CH) 2018-11-29 WO disclosed